The iFuse system is intended for the fixation of large bones and large bone fragments of the pelvis for conditions that include SI joint disruptions and degenerative sacroiliitis. The minimally invasive procedure uses titanium implants coated with a porous plasma spray designed to decrease the implant motion.
Read more coverage of SI-BONE:
– SI-BONE’s iFuse Implant System Receives CE Mark
– SI-BONE Closes $11M Financing for Commercial and Clinical Expansion
– SI-BONE Begins Post-Market Clinical Experience of iFuse Implant Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
